Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Biovaxys Technology Corp (LMNGF)

Biovaxys Technology Corp (LMNGF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Biotechs Zero in on Growing Ovarian Cancer Market as Pivotal Trials Advance Through Regulatory Agencies

Palm Beach, FL – May 3, 2021 Ovarian cancer is the 8th most common cancer among women and ranks 5th in cancer deaths among women, accounting for more deaths than any other cancer of the female reproductive...

BIOV.CN : 0.0600 (-7.69%)
LMNGF : 0.2405 (-7.00%)
CTXR : 3.7500 (+12.36%)
BMY : 58.57 (-0.36%)
RHHBY : 35.3400 (-0.79%)
AZN : 66.27 (-0.20%)
How Biotech Developers Are Working Towards New Diagnostic Solutions to Combat Covid-19

FN Media Group Presents USA News Group News Commentary

BIOV.CN : 0.0600 (-7.69%)
LMNGF : 0.2405 (-7.00%)
ABT : 117.85 (-0.24%)
TMO : 510.98 (-0.63%)
CODX : 0.9325 (-5.81%)
DGX : 162.31 (-0.08%)
Thanks to Accelerated COVID-19 Research, New Therapeutic Vaccines May Soon Be Upon Us

FN Media Group Presents USA News Group News Commentary

LMNGF : 0.2405 (-7.00%)
BIOV.CN : 0.0600 (-7.69%)
BNTX : 119.00 (-1.46%)
MRNA : 41.75 (-4.37%)
REGN : 751.38 (+0.25%)
MRK : 101.27 (+0.11%)
A US Government Interagency Group Defines Three Classes Of SARS-Cov-2 Variants

Palm Beach, FL – March 24, 2021 – While the world has reason to become optimistic about seeing a light at the end of the tunnel, due to the development of vaccines to fight and rein in the current...

AZN : 66.27 (-0.20%)
BIOV.CN : 0.0600 (-7.69%)
LMNGF : 0.2405 (-7.00%)
SRNE : 0.0025 (unch)
NVAX : 8.80 (-5.58%)
MRNA : 41.75 (-4.37%)
BIOVAXYS EXPANDS INTELLECTUAL PROPERTY PORTFOLIO

PATENT FILING TO ADDRESS EMERGING SARS-COV-2 VARIANTS NATIONAL PHASE FILINGS FOR CANCER VACCINE

LMNGF : 0.2405 (-7.00%)
Further Development of Advanced COVID-19 Diagnostic Testing Continues

Palm Beach, FL – March 18, 2021 – While most of the world press has been focused on the vaccine development and implementation, that is not the whole story. Numerable collaborations between governments,...

BIOV.CN : 0.0600 (-7.69%)
LMNGF : 0.2405 (-7.00%)
TNXP : 0.1910 (-0.52%)
SVRA : 3.41 (+1.17%)
ONTX : 0.9953 (-0.47%)
JNJ : 154.12 (-0.27%)
BIOVAXYS ENTERS AGREEMENT WITH INOTIV TO CONDUCT PRECLINICAL TOXICITY STUDIES FOR ITS COVID-T™ IMMUNODIAGNOSTIC PROGRAM

Vancouver, BC –  March 18th, 2021 — BioVaxys Technology Corp. (CSE: BIOV) (FRA:5LB) (OTCPK:LMNGF) (“BioVaxys”), the world leader in haptenized protein vaccines for antiviral and cancer applications,...

BIOV.CN : 0.0600 (-7.69%)
LMNGF : 0.2405 (-7.00%)
Biotechs Step Up Development Activities as U.S. Government Prioritizes Availability Of COVID-19 Vaccines

Palm Beach, FL – March 15, 2021 – The recent pandemic, in one way, is like the WWIII we were hoping would never come. The whole world is fighting…  not against each other, but against a common enemy....

BIOV.CN : 0.0600 (-7.69%)
LMNGF : 0.2405 (-7.00%)
PFE : 25.76 (-1.57%)
MRNA : 41.75 (-4.37%)
JNJ : 154.12 (-0.27%)
NVAX : 8.80 (-5.58%)
BIOVAXYS ENTERS MAJOR BIOPRODUCTION AGREEMENT WITH WUXI BIOLOGICS (HONG KONG) LTD. TO SYNTHESIZE PROTEINS FOR ITS SARS-COV-2 VACCINE AND COVID-T™ IMMUNODIAGNOSTIC PROGRAMS

Vancouver, British Columbia, March 15 th , 2021 —  BioVaxys Technology Corp. (CSE: BIOV, FRA:5LB, OTC:LMNGF) (“BioVaxys”), the world leader in haptenized protein vaccines for antiviral and cancer...

LMNGF : 0.2405 (-7.00%)
As Additional COVID Variants Surface, Questions Arise to Effectiveness of Vaccines to Combat New Strains

Palm Beach, FL – March 1, 2021 – The epic global race to solve the COVID-19 crisis has just gotten a be a more of a puzzle with the emergence of new variants. The existing vaccines have been based...

BIOV.CN : 0.0600 (-7.69%)
LMNGF : 0.2405 (-7.00%)
JNJ : 154.12 (-0.27%)
PFE : 25.76 (-1.57%)
MRNA : 41.75 (-4.37%)
INO : 4.04 (-2.18%)

Barchart Exclusives

2 'Strong-Buy' Energy Dividend Stocks With 51% to 72% Upside in 2025
These top-rated dividend stocks are cheap now. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar